Showing results (111-120 of 459) with videos related to
Sort By:
Pageof 46
Expert Opinion on Biological Therapy|August 4, 2016
Insulin degludec + liraglutide: a complementary combinationK Stinkens, B Peene, C MathieuRevue Medicale Suisse|April 18, 2007
[Pregnancy in patients with underlying renal disease]D Golshayan, C Mathieu, M BurnierDiabetes, Obesity & Metabolism|September 6, 2013
β-Cell differentiation and regeneration in type 1 diabetesL Ding, C Gysemans, C MathieuAutoimmunity Reviews|June 11, 2026
Antigen-specific tolerance therapies in type 1 diabetes: Disease-specific promises meet stage-specific challengesA Wouters, C Mathieu, C GysemansRevue Du Rhumatisme (English Ed.)|April 2, 1998
Frozen shoulder: a new delayed complication of protease inhibitor therapy?L Zabraniecki, A Doub, M Mularczyk, et al.AIDS (London, England)|May 1, 1994
Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBVP Brousset, E Drouet, D Schlaifer, et al.Medecine Et Maladies Infectieuses|July 14, 2007
[Impact of HIV infection on malaria in adults]G Martin-Blondel, M Barry, L Porte, et al.HIV Medicine|March 23, 2012
Factors associated with a strictly undetectable viral load in HIV-1-infected patientsG Martin-Blondel, K Sauné, V Vu Hai, et al.HIV Medicine|November 5, 2005
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patientsL Cuzin, P Pugliese, F Bugnon, et al.Infection|May 28, 2013
FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasisP G Kyrtatos, A Debard, G Martin-Blondel, et al.Pageof 46